Auris Medical says it will advance a treatment for colorectal cancer as its first therapeutic indication for a delivery platform.

Arrowhead's move comes after a toxicology study in rats contained unexpected signals of local lung inflammation, the company says.

Jim Cramer says it seems we're in disarray, and we are. But investors need to keep a sharp eye out for a rebound on the horizon.

Arrowhead Pharma, Kodak, AMC Networks, Cornerstone Building Brands, and Inovio Pharma are some of the top gainers for Wednesday.

Stocks may be down, says Jim Cramer, but it's more about the administration getting tough on China again than it is a weakening economy.

Jim Cramer has a list of 12 presents he'd love to see investors get this holiday season, from a prosperous stock market to a true resolution of the trade wars in the coming year.

Impeachment, trade and tariffs, the yield curve, even the opioid crisis -- Jim Cramer explains why this bull is just trampling these obstacles.

Jim Cramer takes a look at FedEx, Synopsys, Autodesk, Grocery Outlet, Arrowhead Pharmaceuticals and more.

Jim Cramer says too much supply in the stock market can overwhelm the bull.

Home Depot closed out a busy week by naming CEO Ted Decker as chairman, unveiling a new $15 billion buyback and declaring a $1.90 per share dividend.

"Although we're confident in our ability to perform well in a range of market scenarios, we're mindful of the current macroeconomic trends," said CEO Gary Dickerson.

Deere's third quarter profits "reflected higher costs and production inefficiencies driven by the difficult supply-chain situation," said CEO John May.